A previous study revealed that OXA exposure induces the expression of VEGF and VEGF receptors (VEGFR) in human colorectal cancer cells, explaining the benefits of anti-VEGF therapy in combination with chemotherapy for CRC patients100. The gene discussed is KDR; the disease is colorectal cancer.